Coloplast A/S engages in the developing, manufacture, and markets medical products. It operates through the following segments: Chronic Care, Voice and Respiratory Care, Interventional Urology, ...

Coloplast interim CEO Lars Rasmussen has today informed the Coloplast Board of Directors that he will not stand for re-election as board member at the upcoming annual general meeting on December 4, ...

YARMOUTH, Maine – New HCPCS coding changes for intermittent catheters take effect Jan. 1, 2026, and there are steps providers can take now to make sure they are ready, says Kathryn Vaughn, director of ...

Investing.com - Deutsche Bank has reduced its price target on Coloplast A/S (CSE:COLOB) to DKK660.00 from DKK708.00 while maintaining a Hold rating on the stock. According to InvestingPro data, the ...

Coloplast A/S ((GB:0QBO)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...

In relation to the launch of Coloplast’s new 5-year strategy, Impact4, the company announces a new financial ambition with organic revenue CAGR of 7-8% until FY 2029/30, growth in absolute EBIT* in ...

Coloplast delivered organic growth of 7% and an EBIT margin 1 of 28% in Q3. Reported revenue in DKK grew 1% with negative impact from currencies and the Skin Care divestment. Organic growth rates by ...

Superman fans left conflicted about controversial plot twist in new movie Schumer’s shutdown threat could set the stage for Democratic revolt Ukraine under fire: Where does Russia get its ‘endless’ ...

Listen, I love a fun lamp; they can add so much character to a space. But the thing is, they can also be pretty pricey for seemingly no reason at all. The cuter the lamp, the more expensive it is. Yes ...